Drugs / neutral protamine Hagedorn
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00206401 | Nov 2004 → Oct 2006 | type 1 diabetes mellitus | Baylor College of Medicine | Completed | Met primary |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | neutral protamine Hagedorn | “A randomized, controlled trial comparing twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn (NPH) therapy in newly...” PMID 18299307 ↗ Feb 2008 |
| Known as | NPH | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00206401 ↗ |
| Modality | Protein / enzyme biologic | “conventional insulin therapy (i.e. using NPH and Humalog twice daily, injected separately)” NCT00206401 ↗ |